• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱经尿道切除术中尿路上皮癌复发的组织病理学演变:35例连续病例及文献综述

Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review.

作者信息

Koyuncuer Ali

机构信息

Department of Pathology, Antakya State Hospital, Hatay, Turkey. Email:

出版信息

Asian Pac J Cancer Prev. 2017 Feb 1;18(2):459-463. doi: 10.22034/APJCP.2017.18.2.459.

DOI:10.22034/APJCP.2017.18.2.459
PMID:28345830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5454743/
Abstract

Background: Urothelial carcinoma (UC) is the malignancy most frequently encountered in the urinary bladder.The primary aim of this study was to make a reappraisal of histopathologic features, recurrence and progression. Materials and Methods: The records of cases consecutively diagnosed with UC in the state hospital pathology laboratory were collected. Cases were classified according to age, gender, histologic grade, pathologic staging [primary Tumor (pT)] ,tumor configuration, primary or recurrent status, and progression. Results: A total of 35 (29 male and 6 female) cases were examined. The mean age was 68.9 years with a male-to-female incidence ratio of 4.8:1. Low-grade UCs accounted for 20 (57.1%) and high-grade for 15 (42.9%). A papillary pattern was observed in 80% of the UCs, classified into the following pathological stages: 11 (31.4%) pTa, 22 (62.9%) pT1, and 2 (5.9%) pT2 cases. Eleven patients progressed to a higher stage (pT1 to pT2), and three cases from low to higher grade. We analyzed results for 26 (74.3%) cases aged 65 years or older. Conclusions: UCs have a great tendency for recurrence but potentially may be amenable to effective local or systemic treatments.

摘要

背景

尿路上皮癌(UC)是膀胱中最常见的恶性肿瘤。本研究的主要目的是对其组织病理学特征、复发和进展进行重新评估。材料与方法:收集州立医院病理实验室连续诊断为UC的病例记录。病例根据年龄、性别、组织学分级、病理分期[原发肿瘤(pT)]、肿瘤形态、原发或复发状态以及进展情况进行分类。结果:共检查了35例(29例男性和6例女性)。平均年龄为68.9岁,男女发病率之比为4.8:1。低级别UC占20例(57.1%),高级别占15例(42.9%)。80%的UC观察到乳头状模式,分为以下病理分期:11例(31.4%)pTa、22例(62.9%)pT1和2例(5.9%)pT2。11例患者进展到更高分期(pT1至pT2),3例从低级别进展到高级别。我们分析了26例(74.3%)65岁及以上患者的结果。结论:UC有很高的复发倾向,但可能适合有效的局部或全身治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c434/5454743/814337012e77/APJCP-18-459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c434/5454743/814337012e77/APJCP-18-459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c434/5454743/814337012e77/APJCP-18-459-g001.jpg

相似文献

1
Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review.膀胱经尿道切除术中尿路上皮癌复发的组织病理学演变:35例连续病例及文献综述
Asian Pac J Cancer Prev. 2017 Feb 1;18(2):459-463. doi: 10.22034/APJCP.2017.18.2.459.
2
Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.经尿道膀胱肿瘤切除标本中尿路上皮癌的组织病理学评估:单中心八年经验
Asian Pac J Cancer Prev. 2015;16(7):2871-7. doi: 10.7314/apjcp.2015.16.7.2871.
3
Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.p63、p53在膀胱癌中的免疫组化表达。
Indian J Pathol Microbiol. 2013 Jan-Mar;56(1):10-5. doi: 10.4103/0377-4929.116141.
4
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.膀胱尿路上皮癌及卡介苗诱导的肉芽肿中PD-L1(B7-H1)的表达:与局限性疾病进展的关联
Cancer. 2007 Apr 15;109(8):1499-505. doi: 10.1002/cncr.22588.
5
CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.膀胱尿路上皮癌不同分级和分期中CD 10的表达强度
J Coll Physicians Surg Pak. 2014 May;24(5):351-5.
6
Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.大巢状变异型尿路上皮癌:23 例酷似 von Brunn 巢和非浸润性乳头状尿路上皮癌倒置生长方式。
Am J Surg Pathol. 2011 Sep;35(9):1337-42. doi: 10.1097/PAS.0b013e318222a653.
7
Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.经尿道切除术后 T1 期膀胱尿路上皮癌的亚分期对预后的意义。
Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.
8
Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.测量经尿道切除术标本中pT1期尿路上皮癌浸润成分的大小可预测复发时间。
Ann Diagn Pathol. 2014 Apr;18(2):49-52. doi: 10.1016/j.anndiagpath.2013.11.002. Epub 2013 Nov 20.
9
Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.2004 年世卫组织/国际泌尿病理学会分类对预测非肌肉浸润性膀胱尿路上皮肿瘤的复发、进展和癌症特异性死亡率的预后意义:1515 例临床病理研究。
Am J Clin Pathol. 2010 May;133(5):788-95. doi: 10.1309/AJCP12MRVVHTCKEJ.
10
Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.比较 2004 年和 1973 年世界卫生组织分级系统及其与病理分期的关系,以预测尿路上皮癌患者的长期预后。
Urology. 2010 Sep;76(3):593-9. doi: 10.1016/j.urology.2010.01.032. Epub 2010 Apr 8.

引用本文的文献

1
Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma.人表皮生长因子受体2(HER2)与尿路上皮膀胱癌中p53和p63的相关性
Cureus. 2023 Apr 23;15(4):e38018. doi: 10.7759/cureus.38018. eCollection 2023 Apr.

本文引用的文献

1
Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study.韩国非肌层浸润性膀胱癌患者复发和进展的预后因素:一项回顾性多机构研究
Yonsei Med J. 2016 Jul;57(4):855-64. doi: 10.3349/ymj.2016.57.4.855.
2
[Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].[T1期膀胱癌患者重复经尿道切除术后残留肿瘤的临床意义]
Zhonghua Yi Xue Za Zhi. 2016 Apr 12;96(14):1124-7. doi: 10.3760/cma.j.issn.0376-2491.2016.14.013.
3
Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study.
中国人群中pT1期膀胱肿瘤经尿道切除术后首次复发患者复发和进展的预测危险因素:一项回顾性研究
Medicine (Baltimore). 2016 Feb;95(5):e2625. doi: 10.1097/MD.0000000000002625.
4
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
5
Recurrence of high-risk bladder cancer: a population-based analysis.高危膀胱癌复发:基于人群的分析。
Cancer. 2013 Sep 1;119(17):3219-27. doi: 10.1002/cncr.28147. Epub 2013 Jun 4.
6
Epidemiology and risk factors of urothelial bladder cancer.尿路上皮膀胱癌的流行病学和危险因素。
Eur Urol. 2013 Feb;63(2):234-41. doi: 10.1016/j.eururo.2012.07.033. Epub 2012 Jul 25.
7
Best practice in the treatment of nonmuscle invasive bladder cancer.非肌肉浸润性膀胱癌的治疗最佳实践。
Ther Adv Urol. 2012 Feb;4(1):13-32. doi: 10.1177/1756287211431976.
8
Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.低级别乳头状尿路上皮膀胱癌:来自单一学术中心的世界卫生组织/国际泌尿病理学会分类后队列的临床病理分析。
Arch Pathol Lab Med. 2010 Aug;134(8):1160-3. doi: 10.5858/2009-0403-OA.1.
9
Mechanisms of recurrence of Ta/T1 bladder cancer.Ta/T1期膀胱癌的复发机制。
Ann R Coll Surg Engl. 2010 Sep;92(6):519-24. doi: 10.1308/003588410X12664192076935. Epub 2010 Jun 1.
10
Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.2004 年世卫组织/国际泌尿病理学会分类对预测非肌肉浸润性膀胱尿路上皮肿瘤的复发、进展和癌症特异性死亡率的预后意义:1515 例临床病理研究。
Am J Clin Pathol. 2010 May;133(5):788-95. doi: 10.1309/AJCP12MRVVHTCKEJ.